News & Insights from IRC Partners

IRC Partners publishes institutional-grade research on capital stack structuring, GP/LP economics, debt and equity positioning, fund formation, and LP due diligence for real estate sponsors and growth-stage founders raising
$5M to $250M.
Each article is written to the standard institutional investors use to evaluate sponsors, not as general education.

How Right of First Refusal (ROFR) provisions block secondary sales and Series B closings.
IRC Partners Research
April 26, 2026

The Right of First Refusal Problem: How ROFR Provisions on Your Cap Table Block Secondary Sales and Complicate Series B Closing

ROFR provisions are standard in venture deals. Long notice windows and vague waiver mechanics turn them into blocking leverage for legacy holders.
Co-sale rights and tag-along provisions on a startup cap table.
IRC Partners Research
April 25, 2026

Co-Sale Rights and Tag-Along Provisions: The Cap Table Clauses That Force Institutional Investors to Share Their Deal With Your Seed Angels

Co-sale rights let investors sell alongside founders on transfers. Broad thresholds and stacked class elections can shrink a founder's sale block.
How side letters and investor accommodations become Series B diligence landmines.
IRC Partners Research
April 24, 2026

Side Letters and Side Agreements: How Quiet Investor Accommodations Become Series B Diligence Landmines

Side letters grant off-document rights a Series B lead cannot see in main documents. Discovery mid-diligence is a credibility problem, not just a legal fix.
The Delaware flip problem and how late conversion impacts Series B funding.
IRC Partners Research
April 24, 2026

The Delaware Flip Problem: Why a Late Conversion Can Derail a Series B

A Delaware flip is required for institutional Series B financing. Done late, it creates cap table gaps investors must re-underwrite from scratch.
How super pro-rata rights from seed investors crowd out Series B lead investors.
IRC Partners Research
April 23, 2026

Super Pro-Rata Rights: How One Aggressive Seed Investor's Outsized Follow-On Allocation Is Crowding Out Your Series B Lead

Series A protective provisions can block a Series B lead from getting the board seat, governance rights, and approval mechanics it needs to close.
Series A investor rights blocking a Series B lead investor.
IRC Partners Research
April 23, 2026

Your Series A Investors Have Rights That Block the Series B Lead You Want

Consent rights become veto mechanisms when thresholds are fragmented by series. A single small investor can stall your Series B without blocking it outright.
How investor consent rights create governance issues on a cap table.
IRC Partners Research
April 23, 2026

How Investor Consent Rights Turn Your Cap Table Into a Governance Hostage Situation Before Series B

Consent rights become veto mechanisms when thresholds are fragmented by series. A single small investor can stall your Series B without blocking it outright.
Drag-along rights and how they can block a Series B exit or recap.
IRC Partners Research
April 23, 2026

Drag-Along Rights Gone Wrong: The Clause That Lets Minority Investors Block Your Series B Exit or Recap

A defective drag-along clause gives minority holders veto power over your Series B or exit. The leverage is procedural, not proportional to ownership.
The hidden cost of uncapped MFN SAFEs at Series B.
IRC Partners Research
April 22, 2026

The Hidden Cost of Uncapped MFN SAFEs: How Most-Favored-Nation Clauses Silently Reprice Your Entire Seed Round at Series B

Seed terms don't expire at close. Participating preferred, full ratchet anti-dilution, and aggressive pro-rata rights compound into Series B problems.

Schedule A Meeting

You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.

We onboard a maximum of 7
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.